Imperial Oil (AMEX: IMO) is expected to report Q2 earnings on Aug. 1. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Imperial Oil's revenues will grow 13.8% and EPS will expand 28.4%.
The average estimate for revenue is $8.38 billion. On the bottom line, the average EPS estimate is $0.95.
Last quarter, Imperial Oil logged revenue of $7.88 billion. GAAP reported sales were 4.9% higher than the prior-year quarter's $7.19 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.92. GAAP EPS of $0.92 for Q1 were 23% lower than the prior-year quarter's $1.19 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 19.8%, 550 basis points worse than the prior-year quarter. Operating margin was 13.7%, 460 basis points worse than the prior-year quarter. Net margin was 10.4%, 370 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $33.74 billion. The average EPS estimate is $4.10.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 376 members out of 394 rating the stock outperform, and 18 members rating it underperform. Among 92 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 86 give Imperial Oil a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Imperial Oil is hold, with an average price target of $51.76.
Is Imperial Oil the right energy stock for you? Read about a handful of timely, profit-producing plays on expensive crude in "3 Stocks for $100 Oil." Click here for instant access to this free report.
- Add Imperial Oil to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Healthcare: Is Celgene Going to Buy Juno Therapeutics?
A big biotech merger could be in the works.
American Express Earnings Beat Estimates, but It's Not All Good News
Earnings and revenue both surpassed expectations, but the company's tax reform charge and plans to recapitalize are disappointing investors.
What Happened in the Stock Market Today
On a day the indexes pulled back from recent record highs, Wyndham announced it is buying La Quinta, and Alcoa reported disappointing profits.